/Companies

Tactiva Therapeutics

Chicago, US · 3 known investors

Find your way into Tactiva Therapeutics

Sign up to see every warm intro you have to Tactiva Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Tactiva Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Tactiva Therapeutics develops immuno-oncology treatments using adoptive cell therapy approaches for cancer patients. The company leverages innovative methods in T cell engineering and gene therapy to address metastatic and gynecological cancers.

Founders & leadership

RC
Richard C. KoyaCo-Founder
KO
Kunle OdunsiCo-Founder
JZ
Jay ZhangCEO

Investors · 3

Funding

SEC filings, press & company announcements

$35M disclosed across 1 of 2 rounds · 2018

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Tactiva Therapeutics do?
Tactiva Therapeutics develops immuno-oncology treatments using adoptive cell therapy approaches for cancer patients. The company leverages innovative methods in T cell engineering and gene therapy to address metastatic and gynecological cancers.
Who founded Tactiva Therapeutics?
Tactiva Therapeutics was founded by Richard C. Koya, Kunle Odunsi.
Who are Tactiva Therapeutics's investors?
Tactiva Therapeutics's investors include EFung Capital, Panacea Venture, VI Partners.
How much funding has Tactiva Therapeutics raised?
Tactiva Therapeutics has disclosed $35M raised across 1 of its 2 known rounds.
Where is Tactiva Therapeutics headquartered?
Tactiva Therapeutics is headquartered in Chicago, US.